Trombólise com APSAC endovenoso em pacientes com infarto agudo do miocárdio

Ribeiro, Expedito; Silva, Lélio Alves; Petrizzo, Antônia; Torossian, Sérgio P; Oliveira, José Licínio; Buffollo, Enio; Duprat Filho, Renato.
Arq. bras. cardiol ; 57(1): 5-8, jul. 1991. tab
Artículo en Portugués | LILACS | ID: lil-107900

Documentos relacionados

  1. [Thrombolysis with intravenous APSAC in patients with acute myocardial infarction].
  2. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
  3. Anistreplase in early acute myocardial infarction and the one-year follow-up.
  4. [The safety of the treatment of an acute myocardial infarct by immediate intravenous fibrinolysis in the regional hospital environment].
  5. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT).
  6. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.
  7. Prehospital thrombolysis: beneficial effects of very early treatment on infarct size and left ventricular function.
  8. Current issues concerning thrombolytic therapy for acute myocardial infarction.
  9. Thrombolysis: the need for a critical review.
  10. Thrombolytic therapy in acute MI. Weighing the risks and benefits.